HSBC downgrades Pfizer stock to "Hold," target price reduced from $32 to $28
Pfizer (NYSE: PFE) stock closed at $23.72 on July 7, down 2.47% for the day. Over the past month, Pfizer shares fell 6.61%, underperforming the healthcare sector. HSBC analyst Rajesh Kumar downgraded Pfizer from "Buy" to "Hold" and lowered the price target from $32 to $28. HSBC Downgrades Pfizer to "Hold", Beta Raised to 0.85 According to Zacks and Investing.com, HSBC analyst Rajesh Kumar released a pharmaceutical stock rating report on July 7, 2026, taking the following actions on Pfizer and co
MarketWhisper·07-07 02:11






